Development and External Validation of 18F-FDG PET-Based Radiomic Model for Predicting Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer
Open Access
Abstract
The aim of our retrospective study is to develop and externally validate an 18F-FDG PET-derived radiomics model for predicting pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast cancer patients. A total of 87 breast cancer patients underwent curative surgery after NAC at Soonchunhyang University Seoul Hospital and were randomly assigned to a training cohort and an internal validation cohort. Radiomic features were extracted from pretreatment PET images. A radiomic-score model was generated using the LASSO method. A combination model incorporating significant clinical variables was constructed. These models were externally validated in a separate cohort of 28 patients from Soonchunhyang University Buscheon Hospital. The model performances were assessed using area under the receiver operating characteristic (AUC). Seven radiomic features were selected to calculate the radiomic-score. Among clinical variables, human epidermal growth factor receptor 2 status was an independent predictor of pCR. The radiomic-score model achieved good discriminability, with AUCs of 0.963, 0.731, and 0.729 for the training, internal validation, and external validation cohorts, respectively. The combination model showed improved predictive performance compared to the radiomic-score model alone, with AUCs of 0.993, 0.772, and 0.906 in three cohorts, respectively. The 18F-FDG PET-derived radiomic-based model is useful for predicting pCR after NAC in breast cancer.Keywords
Funding Information
- Soonchunhyang University Research Fund (NRF2020M2D9A1094072)
- Korea government (Ministry of Science and ICT) (NRF2020M2D9A1094072)
This publication has 52 references indexed in Scilit:
- Breast cancer intra-tumor heterogeneityBreast Cancer Research, 2014
- Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-AnalysisJournal of Nuclear Medicine, 2014
- Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expressionScientific Reports, 2014
- Development and Evaluation of an Open-Source Software Package “CGITA” for Quantifying Tumor Heterogeneity with Molecular ImagesBioMed Research International, 2014
- Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variabilityActa Oncologica, 2013
- Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Statistical challenges of high-dimensional dataPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2009
- Exploring Tumor Biology with Fluorodeoxyglucose–Positron Emission Tomography Imaging in Breast CarcinomaPET Clinics, 2009
- 18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease CharacterizationJournal of Nuclear Medicine, 2009
- 18F‐fluorodeoxyglucose positron emission tomography/computed tomography (FDG‐PET/CT) imaging in the staging and prognosis of inflammatory breast cancerCancer, 2009